Activity of Gefitinib in a Non-Small-Cell Lung Cancer Patient with Both Activating and Resistance EGFR Mutations

被引：13
|
作者：
Morabito, Alessandro [1 ]
Costanzo, Raffaele [1 ]
Rachiglio, Anna Maria [2 ]
Pasquale, Raffaella [2 ]
Sandomenico, Claudia [1 ]
Franco, Renato [3 ]
Montanino, Agnese [1 ]
De Lutio, Elisabetta
Rocco, Gaetano [3 ]
Normanno, Nicola [2 ,3 ]
机构：
[1] Natl Canc Inst, Med Oncol Unit, Thoracopulm Dept, I-80131 Naples, Italy
[2] Ctr Ric Oncol Mercogliano, Mercogliano, AV, Italy
[3] Natl Canc Inst, Thoracopulm Dept, I-80131 Naples, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷 / 07期
关键词：
D O I：
10.1097/JTO.0b013e318286cc26
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
下载
收藏
页码：E59 / E60
页数：2
相关论文
共 50 条
  • [31] Non-small-cell lung cancer harbouring mutations in the EGFR kinase domain
    Rafael Rosell
    Teresa Morán
    Enric Carcereny
    Vanessa Quiroga
    Miguel Ángel Molina
    Carlota Costa
    Susana Benlloch
    Miquel Tarón
    Clinical and Translational Oncology, 2010, 12 : 75 - 80
  • [32] EGFR Mutations in Non-Small-Cell Lung Cancer Find, Divide, and Conquer
    Morgensztern, Daniel
    Politi, Katerina
    Herbst, Roy S.
    JAMA ONCOLOGY, 2015, 1 (02) : 146 - 148
  • [33] Non-small-cell lung cancer harbouring mutations in the EGFR kinase domain
    Rosell, Rafael
    Moran, Teresa
    Carcereny, Enric
    Quiroga, Vanessa
    Angel Molina, Miguel
    Costa, Carlota
    Benlloch, Susana
    Taron, Miquel
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2010, 12 (02): : 75 - 80
  • [34] Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer
    Kejun Liu
    Guanming Jiang
    Ailing Zhang
    Zhuanghua Li
    Jun Jia
    BMC Cancer, 20
  • [35] Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer
    Liu, Kejun
    Jiang, Guanming
    Zhang, Ailing
    Li, Zhuanghua
    Jia, Jun
    BMC CANCER, 2020, 20 (01)
  • [36] EGFR mutations in patients with non small-cell lung cancer in Bulgaria and treatment with gefitinib
    Damyanov, Danail
    Koynov, Krassimir
    Naseva, Emilia
    Bichev, Stoyan
    JOURNAL OF BUON, 2015, 20 (01): : 136 - 141
  • [37] Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients
    Cortes-Funes, H
    Gomez, C
    Rosell, R
    Valero, P
    Garcia-Giron, C
    Velasco, A
    Izquierdo, A
    Diz, P
    Camps, C
    Castellanos, D
    Alberola, V
    Cardenal, F
    Gonzalez-Larriba, JL
    Vieitez, JM
    Maeztu, I
    Sanchez, JJ
    Queralt, C
    Mayo, C
    Mendez, P
    Moran, T
    Taron, M
    ANNALS OF ONCOLOGY, 2005, 16 (07) : 1081 - 1086
  • [38] Description of a diagnostic case of a non small cell lung cancer patient with activating mutations in the EGFR gene Comment
    Ramlau, Rodryg
    ONCOLOGY IN CLINICAL PRACTICE, 2014, 10 : G19 - G19
  • [39] Cost-Effectiveness Analysis of Gefitinib Plus Chemotherapy versus Gefitinib Alone for Advanced Non-Small-Cell Lung Cancer with EGFR Mutations in China
    Shu, Yamin
    Zhang, Qilin
    He, Xucheng
    Chen, Li
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 8297 - 8306
  • [40] Gefitinib in the treatment of advanced non-small-cell lung cancer
    Reck, Martin
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (04) : 401 - 412
12345